Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates

Pérez, P; Albericio, G; Astorgano, D; Flores, S; Sánchez-Corzo, C; Sanchez-Cordón, PJ; Luczkowiak, J; Delgado, R; Casasnovas, JM; Esteban, M; García-Arriaza, J

Pérez, P; García-Arriaza, J (通讯作者)，Ctr Nacl Biotecnol CNB, Dept Mol & Cellular Biol, Consejo Super Invest Cient CSIC, Madrid, Spain.;Pérez, P; García-Arriaza, J (通讯作者)，Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain.

FRONTIERS IN IMMUNOLOGY, 2023; 14 ():

Abstract

The constant appearance of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VoCs) has jeopardized the protective ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索